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Alzheimer’s disease is characterized by the deposi-
tion of senile plaques and progressive dementia.
The molecular mechanisms that couple plaque
deposition to neural system failure, however, are
unknown. Using transgenic mouse models of AD to-
gether with multiphoton imaging, we measured neu-
ronal calcium in individual neurites and spines in vivo
using the genetically encoded calcium indicator
Yellow Cameleon 3.6. Quantitative imaging revealed
elevated [Ca2+]i (calcium overload) in 20% of neu-
rites in APP mice with cortical plaques, compared
to less than 5% in wild-type mice, PS1 mutant
mice, or young APP mice (animals without cortical
plaques). Calcium overload depended on the exis-
tence and proximity to plaques. The downstream
consequences included the loss of spinodendritic
calcium compartmentalization (critical for synaptic
integration) and a distortion of neuritic morphologies
mediated, in part, by the phosphatase calcineurin.
Together, these data demonstrate that senile pla-
ques impair neuritic calcium homeostasis in vivo
and result in the structural and functional disruption
of neuronal networks.
INTRODUCTION
[Ca2+]i has a ubiquitous role as an intracellular messenger in myr-
iad electrochemical signaling cascades in the central nervous
system (Hara and Snyder, 2007; Kennedy et al., 2005; Khacha-
turian, 1994; LaFerla, 2002; Malenka and Bear, 2004; Mattson,
2004). Mammalian neurons use cues from [Ca2+]i to initiate
such disparate actions as guided growth of axonal fibers during
development (Wen et al., 2004) to initiation of long-term depres-
sion or potentiation in synaptic plasticity (Malenka and Bear,
2004). The role of intracellular calcium in the pathogenesis of Alz-
heimer’s disease has also been postulated (Mattson, 2007;
Smith et al., 2005a). In vitro, both APP and PS1 mutations have
been linked to alterations in calcium handling—but it is unclear214 Neuron 59, 214–225, July 31, 2008 ª2008 Elsevier Inc.which mechanism is relevant in vivo. Existing evidence has
shown that exogenous application of synthetic amyloid-b or olig-
omeric aggregates leads to a rapid and sustained rise in [Ca2+]i in
cultured cells (Demuro et al., 2005; Guo et al., 1999b; Mattson
et al., 1992, 1993). Similarly, the presenilins (PS1 and PS2)
have been closely linked with aberrant [Ca2+]i handling and ap-
pear to result in exaggerated IP3 calcium signaling (Chan et al.,
2000; Stutzmann et al., 2004), enhanced ryanodine-receptor-
mediated calcium release (Chan et al., 2000; Smith et al.,
2005b), a deficit in capacative calcium entry (Akbari et al.,
2004; Leissring et al., 2000; Yoo et al., 2000), and vulnerability
to excitotoxic insult (Guo et al., 1999a, 1999b). Finally, PS1-me-
diated effects on calcium regulation might also occur indepen-
dently of g secretase activity (Akbari et al., 2004; Tu et al., 2006).
However, no direct in vivo data exist to support the proposed
role of calcium in AD pathophysiology. Specifically, technical lim-
itations have prevented examining the relationship between
classical AD pathological alterations and [Ca2+]i, so that the
fundamental question of whether senile plaques disrupt calcium
homeostasis has not been addressed. We have now developed
a multiphoton microscopy-based method to measure [Ca2+]i in
neuronal perykaria and processes in adult living mice and demon-
strate marked elevations of [Ca2+]i in neurites in the immediate vi-
cinity of senile plaques in aged APP or APP/PS1-overexpressing
transgenic mice. We have recently shown that plaque deposition
is critical for the subsequent development of neuritic abnormali-
ties in these models (Meyer-Luehmann et al., 2008). Our current
experiments demonstrate that the plaque-associated disruption
in calcium homeostasis is directly coupled to the development
of advanced morphological changes, including neuritic beading
or blebbing, via activation of calcineurin (CaN, PP2B), providing
a molecular link between amyloid deposition and neuritic abnor-
malities that underlie neural system dysfunction in AD.
We packaged yellow cameleon 3.6, a fluorescence resonant
energy transfer (FRET) based probe (Nagai et al., 2004), into
an adeno-associated virus (AAV2) and expressed this reporter
invivo in the brainsofadult, transgenicmice. YC3.6 fillssoma, den-
drites, axons, and dendritic spines, thereby allowing coincident
measurement of [Ca2+]i and structural morphology—a unique
measurement that would be difficult with small-molecule
calcium indicators such as Fura-2 or Oregon Green BAPTA.
Moreover, we show that YC3.6-expressing neurons respond
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ics. We also show that, unlike other protein-based calcium-sen-
sitive probes, we can accurately measure spontaneous somatic
calcium transients. Most importantly, YC3.6 is a FRET-based ra-
tiometric probe that allows quantitative measurement of calcium
concentration—something not possible with single-wavelength
dyes or fluorescent proteins.
Using the functional calcium-sensitive fluorescent protein tar-
geted to clusters of neurons in the intact brain, we show that
[Ca2+]i is tightly regulated in the brain in vivo. We found that the
resting [Ca2+]i of layer 1 apical tufted dendrites was 80 nM.
Conversely, in mice containing amyloid plaques, we observed
that nearly 20% of dendrites and axons exhibited moderate or
severe calcium overload—the severity of which correlated with
the structural integrity of the dendrite or axon. Amyloid plaque
deposition was required for persistent calcium overload, and
the effect was most pronounced in the local vicinity of individual
plaques. Young APP or PS1 mutant mice did not have resting
calcium levels different than wild-type mice. The neuronal pro-
cesses with the most pronounced calcium overload in APP
mice exhibited neuritic blebbing and beading—a hallmark of
neuronal degeneration that is nearly identical to those found by
classical histopathological methods in AD. Neuronal processes
with moderate levels of calcium overload maintained their struc-
tural integrity; however, we found that, in calcium overloaded
dendrites, the dendritic spines no longer compartmentalized
[Ca2+]i, thereby precluding independent spine signaling along
the dendritic cable. The elevations in [Ca2+]i correlated with neu-
rite beading—a process consistent with activation of CaN. Inhi-
bition of CaN activity with FK-506 in vivo led to a steep reduction
in neuritic beading—while moderate elevations seen in spiny
dendrites and aspiny processes remained unchanged. Thus,
CaN inhibition blocks neuritic beading and prevents further
accumulation of [Ca2+]i. Our data support the hypothesis that
Figure 1. Expression and Calibration in CHO Cells
(A) Diagram of construct pAAV-CBA-YC3.6-WPRE. See
Experimental Procedures for details.
(B–D) CHO cells were incubated with varying [Ca], indicated in
upper right corner, and ionomycin. Relative changes in YFP/
CFP ratio are indicated as DR/DRmax in the bottom right
corner. Images are pseudocolored according to the colorbar.
(E) Ca2+ titration curve of YC3.6 in CHO cells (number of obser-
vations: 0 nM = 1088 cells; 17 nM = 395 cells; 38 nM = 484
cells; 65 nM = 712 cells; 100 nM = 1223 cells; 150 nM =
1518 cells; 351 nM = 425 cells; 602 nM = 144 cells; 1350 nM =
1016 cells; 39 uM = 585 cells). Kd was determined to be
277 nm with a Hill coefficient of 1.1.
amyloid-baggregates induce pathological increases
to [Ca2+]i, which then triggers CaN-dependent
degenerative processes.
RESULTS
YC3.6 Expressed in Cultured Cells
YC3.6 is a ratiometric calcium indicator with a dy-
namic range that covers the ‘‘normal’’ physiological
range of neuronal [Ca2+]i—this makes it particularly well suited
for measuring resting [Ca2+]i. We calibrated YC3.6 in CHO cells
by varying extracellular [Ca] in the presence of the calcium iono-
phore, ionomycin (Figure 1). YC3.6 reports increases in [Ca2+]i as
an increase in the ratio of YFP to CFP fluorescence (construct in
Figure 1A). We saw a nearly 4-fold increase in ratio at high [Ca2+]i
(R0 = 0.87, RMAX = 3.32). We calculated the Kd of YC3.6 to be
277 nM with a Hill coefficient of 1.1 (Figure 1E). These values of
KD and n match well with the published in vitro data (Kd =
250 nM, n = 1.7) (Nagai et al., 2004); our measured values were
used for all subsequent [Ca2+]i calibrations. Cultured mouse neo-
cortical neurons were transfected with YC3.6, and the resting
[Ca2+]i of proximal processes was determined to be 41 nM ± 7
nM (n = 5 dishes, 48 neurons, Figure S1 available online), which
corresponds well with published reports—this confirms that
YC3.6 accurately reports [Ca2+]i in neocortical neurons (Cox
et al., 2000; Helmchen et al., 1996).
Functional Expression of YC3.6 in the Murine Brain
YC3.6-AAV2 was stereotactically targeted to layer 5 pyramidal
neurons of the neocortex of mice in vivo. Figure 2 shows
in vivo expression in layer 5 neuronal soma (2A) and superficial
(<120 mm below the surface) dendrites and axons (Figures 2B–
2D). Hundreds of neurons were infected from a single injection,
with YC3.6 evident within 2 weeks and lasting more than 8
months after viral injection. Dendritic spines were easily resolved
at higher magnification, and spiny dendrites in layer 1 were prev-
alent. We examined the response characteristics of YC3.6 in vivo
by local micropipette injections of glutamate (Figure 3). Areas
with neurites and spines expressing YC3.6 were identified, and
calcium transients were measured in response to application
of glutamate (Figure 3A). Single puffs of glutamate (10 mM in
the pipette) were sufficient to evoke [Ca2+]i transients in den-
drites (Figure 3B); peak, nonaveraged responses in all dendritesNeuron 59, 214–225, July 31, 2008 ª2008 Elsevier Inc. 215
Neuron
In Vivo Calcium Imaging in Alzheimer Mouse Modelshad an average amplitude (DR/R) of 56% ± 1% (mean ± SEM,
n = 16). In all cases, the dendritic [Ca2+]i returned to the baseline
ratio with an average decay constant of 1.30 ± 0.04 s (mean ±
SEM, n = 16). [Ca2+]i increased, on average, from 78 nM to three
times that, 243 nM, during glutamate stimulation. Increasing
amounts of glutamate (approximated by coinjection with a red
fluorescent dye) yielded larger-amplitude and longer-duration
calcium responses (Figure 3C).
One concern with fluorescent calcium-sensitive proteins in-
volves their limited efficacy in measuring spontaneous activity
known to be present in cortical neurons. We imaged somatic
spontaneous calcium transients in layer 5 pyramidal neurons
and confirmed that YC3.6-AAV2 exhibited good temporal kinet-
ics (tdecay = 0.43 ± 0.05 s, duration = 0.86 ± 0.06 s, n = 68 tran-
sients in 2 mice) and robust changes in YFP/CFP ratio (DR/R =
68.7% ± 3.8%, n = 68 transients in 2 mice, see Figure S2). The
robust expression, response to glutamate, concomitant return
to baseline concentration, and measurable spontaneous activity
provide evidence that the cameleon-based indicator, YC3.6, not
only expresses in vivo but provides a quantitative functional
readout of neuronal [Ca2+]i dynamics.
Intracellular Calcium Is Highly Regulated In Vivo
The [Ca2+]i in neurites in WT mice was tightly regulated (Figures
4A and 4C): the resting [Ca2+]i in all morphologically normal spiny
and aspiny processes was 77 nM (65–91 nM) (range is one geo-
metric SD away from the geometric mean). There was no appre-
Figure 2. In Vivo Expression of YC3.6-AAV
(A–D) In vivo multiphoton images deep in the
neocortex of adult mice. (A) Cell bodies 300–550 mm
below the brain surface. (B) Full-field images of
YC3.6-filled neurites and fluorescent angiogram
(red). (C) High-resolution images of axons,
dendrites, and spines in layer I of a wild-type
mouse. (D) Higher-magnification images of a den-
dritic tree and corresponding spines. Detailed
analysis of cellular and subcellular morphology
was possible with YC3.6.
ciable difference between 3.5-month-
old and 6.5-month-old animals (see
Figure S1). Rare examples (2.2%) of
neurites with calcium overload were ob-
served in these mice (defined as a sus-
tained [Ca2+]i greater than two geometric
SD above the geometric mean of all pro-
cesses in WT mice, 147 nM). A log-normal
distribution of [Ca2+]i accurately de-
scribed the range of [Ca2+]i seen in WT
mice (r2 = 0.99). To confirm that our
[Ca2+]i measurements reflected resting
[Ca2+]i, we imaged a subset of neurites
several minutes after the first measure-
ment and confirmed that a similar [Ca2+]i
was maintained (p = 0.57, Wilcoxon
signed-rank test, n = 28). Furthermore,
we used relatively slow (8 s per frame),
high-resolution (512 3 512 or 1024 3 1024 pixels) scans—our
measurements reflect, therefore, an integrated ‘‘resting’’ [Ca2+]i
that is unlikely to be significantly affected by transient increases
in [Ca2+]i in neurites.
Calcium Overload in Neurites of APP/PS1 Transgenic
Mice with Cortical Plaques
We next sought to determine whether calcium overload occurred
in the dendrites and axons in transgenic mice with mutations rel-
evant to AD. To do this, we measured the resting [Ca2+]i in four
transgenic mouse lines (and associated controls): APPswe/
PS1-DE9 double mutants, Tg-2576 (APPswe only), PS1-DE9
only, and PS1M146V only. The APP/PS1 mutant mice typically
develop amyloid-b plaques at 4.5–5 months of age (Garcia-
Alloza et al., 2006), whereas the Tg-2576 develop them later—
at approximately 14–15 months. Neither of the PS1 mutant
mice develops any amyloid-b plaque pathology.
In the APP/PS1 transgenic mouse line, a large number of den-
drites and axons exhibited far higher [Ca2+]i than wild-type mice
(see Figures 4B and 4D, p < 0.001, n = 1275 total neurites, Mann-
Whitney U test). As before, calcium overload was defined as
a [Ca2+]i at least two SD above the mean of neurites from
nontransgenic mice (147 nM). APP/PS1 mice had nearly ten
times the number of processes that crossed this threshold
when compared to nontransgenic mice (20% versus 2.2%,
Figure 4E, p < 0.001, c2 test). Different populations of neurites
were readily apparent in images pseudocolored for calcium216 Neuron 59, 214–225, July 31, 2008 ª2008 Elsevier Inc.
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grams of [Ca2+]i for all axons and dendrites suggested that the
transgenic mice had a bimodal distribution, which allowed us
to model the data as a sum of two log-normal distributions
(r2 = 0.99, Figure 4D). The first Gaussian exactly matched that
seen in nontransgenic mice: mean = 77 nM (63–94 nM). The sec-
ond peak was shifted far to the right, was 6-fold higher, and was
broadened: mean = 499 nM (162–1535 nM).
To test whether APP/PS1 mutations effect calcium overload
before plaque deposition, we examined whether [Ca2+]i -elevated
neurites existed in younger, 3- to 3.5-month-old APP/PS1 mice—
an age prior to the development of plaques but consistent with ro-
bust transgene expression (Garcia-Alloza et al., 2006; Jankowsky
et al., 2001). [Ca2+]i was not appreciably disturbed in the neurites
of these mice (see Figure S3). The distribution of [Ca2+]i was signif-
icantly different from APP/PS1 mice with plaques (p < 0.001, Stu-
dent’s t test, see Figure S3 for comparison of distributions). Only
2.3% of neurites in these young transgenic animals had a [Ca2+]i
greater than two SD above the nontransgenic mean (p = 0.731
when comparing 3- to 3.5-month-old APP/PS1 transgenic and
>6.0-month-old APP/PS1 nontransgenic), which was significantly
less than in APP/PS1 mice with plaques (20.2%, p < 0.001).
Calcium Overload Requires Amyloid-b Plaques
The APP/PS1 transgenic mouse model provided clear evidence
for calcium overload in a subpopulation of neurites. The primary
advantage of this mouse model is the accelerated plaque depo-
sition (by 4.5–5 months of age) compared to the Tg-2576
(APPswe only). Since both the APPswe and PS1-DE9 have
been implicated in impaired calcium regulation, we next tested
which of these mutations might be responsible for the calcium
overload by measuring the resting [Ca2+]i in aged Tg-2576
(APPswe) mice and, separately, PS1-DE9 mice. To ensure that
there is no effect of background strain, and age, on resting levels
of calcium, we compared the Tg-2576 against age-matched non-
transgenic from the same background strain (n = 3 transgenic
mice, n = 2 nontransgenic mice). The PS1-DE9 mutant mouse
Figure 3. In Vivo Imaging of Glutamate-
Evoked Ca2+ Transients
(A) High-resolution multiphoton image of dendrites
and spines in vivo. The calcium response to micro-
pipette injections of glutamate is described in
trace (C).
(B) Dendrites from three different animals showing
responses to small puffs of glutamate (10 mM).
Calcium transients were measured as DR/R and
averaged 56% ± 1% (n = 16 dendrites).
(C) Peak calcium response and the decay con-
stant increased with increased glutamate. Local
glutamate concentration was approximated by
coinjecting a red fluorescent synthetic dye.
line shares the same background as the
APP/PS1 double transgenics, so we use
age-matched mice in this instance (n = 2
transgenic mice, n = 3 nontransgenic).
The Tg-2576 mice exhibited severe cal-
cium overload in the dendrites and axons
that were measured, nearly identical to that seen in APP/PS1
mice (p < 0.001, Mann-Whitney U test, see Figures S4A and
S4C for image and histogram). Twenty-two percent of all den-
drites and axons exhibited calcium overload, compared to 4.5%
in the nontransgenics (p < 0.001, c2 test, Figure 4E). The 4.5%
in the age-matched controls is higher than in the APP/PS1 mice
(2.2%, p = 0.045), but this small difference can be attributed to
the difference in age (6–8 months for the APP/PS1 versus >17
months for the Tg-2576) and background strain.
We imaged calcium concentration in transgenic mice express-
ing different mutant PS1 transgenes in the absence of human
APPmutations.These mice donot develop amyloid-bplaques de-
spite strong expression of the transgene. Neither the PS1-DE9
nor the PS1M146V mutant mice exhibited any appreciable
calcium overload compared to their respective controls (p =
0.77 for PS1-DE9, p = 0.21 for PS1M146V, Figure 4E). In the
PS1-DE9 mice, 2.6% of neurites were overloaded with calcium
compared to 2.2% in control (see Figures S5A and S5B for image
and histogram). This suggests that although the PS1 mutation
helps accelerate plaque deposition in the APP/PS1 transgenic
line, a PS1 mutation alone is not sufficient to induce the calcium
overload that we observe. These data suggest that mutant forms
of PS1, known to have strong effects in fibroblasts and other re-
duced preparations, do not impact resting neuronal [Ca2+]i in
neurites in vivo. This does not preclude, however, more subtle
changes in intracellular calcium handling, perhaps in the peri-
karya, or the existence of compensatory mechanisms that may
mask the effect of presenilin mutations on calcium handling.
Ab Plaques Are a Focal Source of Toxicity Leading
to Calcium Overload
To examine the cause of the increased [Ca2+]i in APP mice, we
next determined whether Ab plaques had a localized effect on
[Ca2+]i. Plaques were concurrently imaged by injecting me-
thoxy-XO4, a fluorescent amyloid binding dye (Klunk et al.,
2002). We classified the [Ca2+]i as either overloaded (two SD
above the average resting [Ca2+]i in nontransgenic mice) orNeuron 59, 214–225, July 31, 2008 ª2008 Elsevier Inc. 217
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APP/PS1 Transgenic Mice with Cortical
Plaques
In vivo image of dendrites and axons in aged non-
transgenic (A) and transgenic (B) mice. Images are
pseudocolored according to [Ca2+]i. (C and D) His-
tograms of [Ca2+]i (YFP/CFP ratio on lower x axis
and [Ca2+]i on upper x axis). Tg mice had a distinct
distribution (D)—modeled as the sum of two
Gaussians (red line, r2 = 0.99)—compared to
Non-Tg mice ([C], single Gaussian, red line, r2 =
0.99). The black line corresponds to two standard
deviations above the mean [Ca2+]i in non-Tg mice
(147 nM)—above this line was classified as cal-
cium overloaded. Twenty percent of neurites in
Tg mice were overloaded compared to only
2.2% in non-Tg mice—a 10-fold increase (n = 3
mice in each group). (E) A comparison of the per-
centage of calcium-overloaded neurites across
four different transgenic mouse lines (mean ±
SEM). Only the APP/PS1 and the Tg-2576
(APPswe only) transgenic mice had significantly
higher number of neurites with elevated calcium
(*p < 0.001, c2 test). PS1 mutant mice that did
not exhibit plaques showed no appreciable cal-
cium overload when compared to their respective
controls (p = 0.77 for PS1-DE9 and p = 0.21 for
PS1M146V). The PS1-DE9 mice are on the same
background as the APP/PS1 transgenic mice—di-
rectly comparing the calcium overload between
these mice and the APP/PS1 shows that the
APP/PS1 mice that develop plaques have a signif-
icantly higher calcium overload (20.2% versus
2.6%, p < 0.001, c2 test).normal and then determined the fraction of calcium-overloaded
neurites at discrete distances from the nearest senile plaque. A
greater proportion of neurites with calcium overload existed
near plaques when compared to further away. Thirty percent of
all neurites within 25 mm of a plaque exhibited strongly elevated
[Ca2+]i compared to 17% farther away (p < 0.05, Fischer exact
test, n = 430). Furthermore, a gradient of [Ca2+]i overload was ev-
ident (Figure 5), with the fraction of calcium-impaired neurites
highest closest to plaques (0–10 mm: 33%, n = 30) and slightly
less at greater distances (10–30 mm: 26%, n = 78). Beyond 30
mm away from the plaque there was no relationship between pla-
que distance and impaired calcium (30–55 mm: 17%; 55–85 mm:
18%; p > 0.5, n = 352). These results indicate that the immediate218 Neuron 59, 214–225, July 31, 2008 ª2008 Elsevier Inc.microenvironment of an Ab plaque focally disrupts neuronal
[Ca2+]i handling and function and that calcium overload can be
detected (although in a lower percentage of neurites) even at dis-
tances farther from a plaque. The extent of disruption is marked:
compared to the number of neurites with [Ca2+]i > two SD from
the mean in controls, the number near a plaque is elevated about
15-fold.
Spino-Dendritic Calcium Compartmentalization
Is Disrupted in Mice with Plaques
Calcium overload might have several downstream functional
consequences. One such consequence would be altered spino-
dendritic compartmentalization. The ability of the dendritic spineFigure 5. Ab Plaques Are a Focal Source of Toxicity
Leading to Calcium Overload
(A) In vivo image YC3.6 expressing dendrites and axons sur-
rounding Ab plaques (labeled in white). Elevated calcium
was seen in neurites (in red) alongside neurites with normal
calcium (in blue).
(B) Within 25 mm of a plaque, there was a significantly higher
probability of finding a calcium-overloaded neurite (p < 0.05,
Fisher-Irwin test, mean ± SEM). The fraction of impaired neu-
rites in non-Tg mice (2.2%) is shown as reference (blue dotted
line). Note that even far from a plaque the percentage of cal-
cium-overloaded neurites is much greater than in non-Tg
mice.
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cium Compartmentalization in Mice with
Plaques
(A) Dendritic spines were identified, and regions of
interest were drawn in ImageJ to isolate the spine
from the dendritic compartment at the base of the
spine.
(B) The spine calcium is plotted against the den-
drite calcium for each spine-dendrite pair for
spines from transgenic (red) and nontransgenic
(blue) animals. The blue dotted lines demarcate the
threshold calcium overload ([Ca2+]i > 147 nM).
Unlike in the nontransgenic animals (blue), a large
number of transgenic spines have a significantly el-
evated [Ca2+]i, consistent with data from dendrites
and axons.
(C) The inset schematic highlights which part of the
calcium distribution is being analyzed in the figure.
Calcium is compartmentalized between normal-
calcium spines and the local dendritic base—there
was no statistically significant correlation between
the spine versus dendrite calcium (R2 = 0.26).
(D) Spine calcium is plotted against dendrite
calcium for all elevated-calcium dendrites in the
APP/PS1 mice. The inset highlights the part of
the calcium distribution that is being analyzed. A
strong correlation exists between the spine cal-
cium and the associated dendritic compartment
(R2 = 0.77) with a slope of 0.85, suggesting that
the spine and dendrite are nearly completely
coupled. Data are from n = 5 transgenic, n = 5
nontransgenic mice.to compartmentalize calcium has been shown to be important
for proper neuronal signaling and synaptic communication
(Araya et al., 2006). A large fraction of the calcium-overloaded
processes imaged in the APP mice maintained their spinoden-
dritic morphology, so we used high-resolution three-dimensional
images of dendrites and axons to investigate spine-level calcium
effects. 3438 dendritic spines (n = 5 transgenic and 5 nontrans-
genic mice) were manually identified, and their local calcium
concentration was measured alongside the parent dendritic
base (see Figure 6A for schematic). Figure 6B shows that, like
dendrites and axons, a large number of dendritic spines in trans-
genic animals have a markedly elevated calcium concentration.
To test whether the spine acts as a distinct compartment from
the parent dendrite (as has been postulated) (Carter et al.,
2007), we paired each spine with its local dendritic base and cre-
ated a scatter plot of the respective [Ca2+]i values. A slope (m) of
1.0 with a strong correlation (R2) would indicate that the spine
and the parent dendrite have the same [Ca2+]i—a slope of zero
or a weak correlation would provide evidence that the spine op-
erates independently of the dendritic base. For all normal-cal-
cium dendrites (n = 2977 spines), the associated spines act as
independent compartments in which there is no significant cor-
relation between the spine and dendritic base (R2 = 0.26). This
holds true for normal-calcium dendrites in both nontransgenic
(n = 1647 spines in 5 animals, R2 = 0.25) and transgenic mice
(n = 1330 spines in 5 animals, R2 = 0.26, Figure 6C). In dendrites
with elevated calcium ([Ca2+]i > 147 nM), present uniquely in the
cortex of mice containing plaques, this compartmentalization is
lost (Figure 6D, n = 461 spines in 5 animals). Indeed, there isa strong correlation between the spine and dendrite [Ca2+]i
(R2 = 0.77) with a slope nearing one (m = 0.85). In this case, spine
and dendrite [Ca2+]i scale with each other, no longer allowing
independent calcium signaling, suggesting the loss of a crucial
mechanism important for dendritic signal integration (Carter
et al., 2007).
Elevations in [Ca2+]i Underlie the Morphological
Changes in Neuronal Processes
We have recently shown that plaques induce neuritic dystro-
phies within a radius of 25 mm, similar to the region noted to
have neurites with an increased chance of elevated [Ca2+]i
(Meyer-Luehmann et al., 2008). Using a detailed morphometric
analysis, we determined that calcium overload occurred in neu-
rites with normal (both aspiny and spiny) and altered (beaded)
morphology (Figures 7A–7C). In control mice, 83.1% of all neu-
ritic processes in layer 1 were spiny dendrites, aspiny processes
made up 15.4%, and beaded and dysmorphic neurites were
rarely seen (<1.5%). We next separated neurites from mice
with amyloid plaques into two functional groups (normal and cal-
cium overloaded) and classified the morphology for both groups.
The normal [Ca2+]i processes had a nearly identical morpholog-
ical distribution as neurites in wild-type mice (Figure 7D). In
contrast, neurites with abnormal morphology were strongly over-
represented in the calcium-overloaded group (Figure 7D). About
half of all identified processes were either beaded, blebbed, or
dysmorphic. The remaining half maintained a normal morphol-
ogy—26% were classified as spiny dendrites and 21% as aspiny
processes. As expected, the spiny:aspiny ratio fell from 4:1 toNeuron 59, 214–225, July 31, 2008 ª2008 Elsevier Inc. 219
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Distortions to Neuritic Morphologies
(A) A [Ca2+]i -elevated ‘‘beaded’’ neurite (1) inter-
digitates with a morphologically and functionally
normal dendrite (2).
(B) Beaded (1–3) neurites adjacent to a senile
plaque (in white) exhibit high [Ca2+]i.
(C) Structurally intact spiny dendrites (1–3) and
structurally compromised beaded neurites (4 and
5) adjacent to a senile plaque (in white) exhibit
significantly elevated [Ca2+]i.
(D) The morphological breakdown of nontrans-
genic neurites matches that seen in [Ca2+]i normal
neurites in transgenic mice. [Ca2+]i-elevated
neurites, however, show a marked difference in
morphological categorization.
(E). Resting [Ca2+]i differs between morphologi-
cally normal and abnormal neurites (mean ±
SEM) in the calcium-overloaded neurite pop-
ulation (p < 0.001, Mann-Whitney test).1:1 near plaques—more processes lacked spines near plaques
(Spires et al., 2005). We then compared the [Ca2+]i of the different
morphological classes in the calcium-overloaded group and
found that there was a strong relationship between morphology
and resting [Ca2+]i (Figure 6E). Calcium-overloaded aspiny pro-
cesses and spiny dendrites (normal morphology) had an average
[Ca2+]i of 395 nM (195–801 nM) (6-fold greater than normal
[Ca2+]i). [Ca
2+]i in beaded and dysmorphic neurites was signifi-
cantly different than this—955 nM (406–2240 nM) (p < 0.001, Wil-
coxon Mann-Whitney test, n = 135)—a striking 12-fold elevation
of [Ca2+]i. The observation that [Ca
2+]i increased as the morphol-
ogy shifted from normal to abnormal suggests that profound
morphological changes are associated with sustained increases
in [Ca2+]i. Since we also observed large numbers of neurites that
were morphologically normal but had marked [Ca2+]i elevations,
morphological changes appear to represent only a subset of
functionally altered dendrites in the cortex of mice with amyloid
plaques. Thus, our in vivo functional pathology approach
provided a window into diseased processes that could not be
readily identified on the basis of morphological inspection alone.
Calcineurin Inhibition Prevents Neuritic Beading
and Severe Calcium Overload
Elevated [Ca2+]i might also lead to downstream activation of sig-
naling pathways important for cell death or survival. We next
asked the question of whether the neuritic beading morphology,
and corresponding severe elevations in intracellular calcium,
could be antagonized by inhibiting the Ca2+/calmodulin-depen-
dent protein phosphatase 2B (calcineurin, CaN). We postulated
that a moderate rise in intracellular calcium would be sufficient
to activate CaN (Shankar et al., 2007; Wen et al., 2004)—in cer-
tain conditions, increased CaN activity has been shown to lead
to neurite degeneration and, more specifically, neuritic beading
(Zeng et al., 2007). Moreover, recent behavioral data suggests220 Neuron 59, 214–225, July 31, 2008 ª2008 Elsevier Inc.that inhibiting CaN restores associative learning and memory in
adult APP mice (Dineley et al., 2007). Taken together, we posited
that a moderate elevation in [Ca2+]i, induced by amyloid-b, initi-
ates a signaling cascade that triggers excessive CaN activity.
We treated animals with FK-506 (10 mg/kg, ip), a potent CaN
inhibitor, daily for 7 days in APP/PS1 transgenic mice with estab-
lished senile plaques. On day 7, we performed a craniotomy and
measured, in vivo, the resting [Ca2+]i in the dendrites and axons
of neurons in the cortex. As with untreated APP/PS1 mice, we
found a substantial subset of dendrites and axons with calcium
overload (n = 3 FK-506-treated mice and 290 neurites, n = 3
sham-treated mice and 578 neurites, Figure 8A). However, the
average resting [Ca2+]i in the calcium-overloaded group of pro-
cesses was substantially reduced when compared to sham-
treated mice (p < 0.01, Mann-Whitney U test, Figure 8C). To
understand this reduction, we visually identified the morphology
of all of the processes and separated them into three classes, as
in Figure 6: aspiny, spiny, or beaded/dysmorphic. In Figure 6, we
showed that calcium overload is more pronounced when the
axon or dendrite appeared abnormal—either as a beaded or
dysmorphic morphological structure. In the FK-506-treated
mice there was a marked reduction in the number of beaded
and dysmorphic processes (Figures 8B and 8D). Only 33% of
calcium-elevated processes exhibited an abnormal morphol-
ogy—compared to 54% in untreated and sham-treated mice,
a reduction of almost 55% (p < 0.05, c2 test). Thus, we see a shift
in the ‘‘class’’ of calcium overload (from severely overloaded
beaded processes to moderately overloaded normal pro-
cesses). Surprisingly, this is augmented by a downward shift in
the intracellular calcium of beaded processes but not in those
that are morphologically intact, suggesting a feedback loop be-
tween calcineurin and [Ca2+]i (p < 0.05 for beaded processes and
p = 0.6087 for normal processes, Student’s t test, Figure 8E).
This provides clear evidence that CaN plays an important role
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Neuritic Beading and Severe Calcium Over-
load
(A) Pseudocolored multiphoton image of trans-
genic mouse treated with FK-506. Daily intraperi-
toneal injection of FK-506 (10 mg/kg) prevented
the neuritic beading and severe calcium overload
typically seen in APP/PS1 mice near plaques (in
white).
(B) Multiphoton image of APP/PS1 mouse that
was sham treated. Moderate and severe cal-
cium-overloaded neurites surround a plaque with
varying morphologies.
(C) In the calcium-overloaded neurites, there was
a significant reduction in the resting calcium
(p < 0.01, Mann-Whitney U test).
(D) The reduction in [Ca2+]i can be explained by
a reduction in the percentage of neurites that
exhibit neuritic beading—only 33% of calcium-
overloaded neurites exhibit a beaded and severe
elevation of [Ca2+]i compared to 54% in sham
treatment (n = 3 mice in each group, n = 159
calcium-overloaded neurites, p < 0.05, c2 test).
(E) Morphologically normal processes (spiny den-
drites and aspiny processes) exhibit nearly the
same [Ca2+]i in FK-506-treated or sham-treated
mice (n = 82 neurites, p = 0.6807, Student’s t
test), whereas there is a slight, but significant,
reduction in the [Ca2+]i in those neurites with an
abnormal morphology (n = 87 neurites, p < 0.05,
Student’s t test). All error bars are mean ± SEM.downstream of the pathological elevations in [Ca2+]i we
observed in the transgenic mice. Thus, CaN inhibition partially
retards the progressive structural and functional degeneration
of vulnerable axons and dendrites.
DISCUSSION
Alzheimer’s disease is defined by the deposition of senile
plaques, neurofibrillary tangles, and progressive neuronal loss.
A longstanding controversy surrounds what precedes the neuro-
degeneration—what is the trigger, or series of triggers, that leads
to neuronal dysfunction and, subsequently, neural system fail-
ure? Pinpointing the discrete stages at which neurons degener-
ate will elucidate targets for therapeutic intervention. A growing
body of evidence has suggested that calcium dyshomeostasis
might be an important, and possibly critical, step toward initiat-
ing cell death mechanisms. Most of this evidence, however,
comes from reduced systems in which cultured cell lines or
acute brain slices are used to study the intracellular regulation
of calcium. These reports demonstrated that exogenous amy-
loid-b application or expression of mutant PS1 can lead to
altered calcium levels. Without measuring such changes in an
intact neural system, and alongside AD-relevant pathology, it is
difficult to draw conclusions as to whether calcium overload is
indeed relevant in AD and, just as importantly, which mecha-
nisms might be responsible.
In vivo multiphoton microscopy provides an ideal approach to
measure changes to brain structure and function in aged, adult
mouse models. To accurately measure intracellular changes in
calcium in neuronal processes along with neuritic morphologyrequires a fluorescent probe that can fill not only soma but also
dendrites, axons, and spines. We found that yellow cameleon
3.6 when expressed via an adeno-associated vector (AAV2)
allowed such a measurement. As a FRET-based probe, it is ca-
pable of reporting quantitative [Ca2+]i when calibrated appropri-
ately. Just as importantly, it exhibits relatively fast kinetics and
robust response properties to physiologically relevant stimuli,
making it useful for a wide variety of neuroscientific applications.
We exploited gene transfer and intravital multiphoton micros-
copy to image YC3.6 in layer 5 pyramidal neurons in transgenic
mice that have mutations associated with AD—both mutations in
APP and PS1.
We found that amyloid-b plaque deposition was required to
induce calcium overload. This was confirmed using four different
mouse models—two of which develop plaques: the APPswe/
PS1-DE9 mouse line, which has an accelerated deposition of
plaques, and the Tg-2576 (APPswe) line. No calcium overload
was seen in either of the PS1 mutant mice (PS1-DE9 or PS1-
M146V) that we investigated. Importantly, neither of these
FAD-linked mutations alone leads to plaque deposition. Further-
more, in 3.5-month-old APP/PS1 transgenic mice, an age before
plaque deposition, there was no appreciable calcium overload.
These data provide evidence that mutant PS1, though important
in accelerating plaque deposition when coupled with mutant
APP, does not play a role in the calcium overload in neurites
that we measured. It does not preclude, however, a more subtle
role for mutant PS1 in calcium handling. In fact, based on recent
evidence from acute brain slices in multiple transgenic mouse
lines, it is likely that PS1 mutations might affect intracellular cal-
cium signaling by modulating release from the ER (StutzmannNeuron 59, 214–225, July 31, 2008 ª2008 Elsevier Inc. 221
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might work alongside the calcium overload we describe.
The calcium overload we observed in vivo in transgenic mouse
models was coupled to the deposition of senile plaques and was
most pronounced in the immediate vicinity of senile plaques.
This suggests that senile plaques are the proximal event in the
cascade but does not preclude a diffusible toxic species, e.g.,
Ab oligomers, enriched near plaques. We propose a multistage
degenerative process in which amyloid-b aggregates induce
calcium influx as an initial acute trigger. The resulting moderate
calcium overload initiates a second pathological stage that acti-
vates the phosphatase, CaN. Increased CaN activity then trig-
gers the final stage of neurite structural degeneration and even
more severe calcium overload. Recent evidence suggests that
CaN activation is directly linked to dendritic structural degener-
ation and neuritic beading (Zeng et al., 2007). By inhibiting CaN
with FK-506, we showed that we can prevent the third stage—
structural degradation of calcium-overloaded morphologically
intact dendrites and axons—thereby halting the progressive de-
generation at an intermediate phase. In behavioral studies, CaN
inhibition with FK-506 partially restored learning and memory in
Tg-2576 mice (Dineley et al., 2007). Our data now allow a mech-
anistic interpretation of these results. We suggest that the resto-
ration of behavioral deficits may reflect the prevention of neuritic
beading and severe calcium overload that otherwise would irre-
versibly interrupt neural circuit function important for learning
and memory.
We have also shown another major functional consequence of
calcium overload: disruption of the spinodendritic signaling
interface. Normally, spines compartmentalize calcium from the
local parent dendrite, thereby allowing independent signaling
of multiple spines along the same dendritic cable. Dendrites
overloaded with calcium no longer have spines that can com-
partmentalize their calcium. Rather, the dendrite and spine are
fully coupled, no longer allowing independent signaling events.
This deficit may underlie the neuronal network dysfunction in AD.
Taken together, the activation of CaN and the alterations of
spinodendritic coupling suggest another important conse-
quence—one with specific implications for cellular mechanisms
of learning and memory. The calcium overload in layer 1 spiny
dendrites in APP mice was500 nM; this range is similar in mag-
nitude to levels that have been associated with long-term de-
pression (LTD) of synaptic strength (Sabatini et al., 2002), sug-
gesting a link between the cellular mechanisms of LTD and the
pathophysiology of AD. Multiple lines of evidence have shown
that activation of CaN leads to LTD (Malenka and Bear, 2004;
Mulkey et al., 1994)—taken together, we posit that the calcium
overload and subsequent CaN activation is sufficient to induce
LTD. This hypothesis is further supported by evidence that a sus-
tained increase in [Ca2+]i can initiate LTD (Tanaka et al., 2007)
and that local application of Ab can induce LTD-like mechanisms
in vitro (Snyder et al., 2005).
The calcium overload we observed in the transgenic animals
and associated LTD mechanisms could contribute to the re-
duced spine density present throughout the cortex and which
is particularly striking within 25 mm of a senile plaque (Spires
et al., 2005). Our in vivo data suggest that calcium overload is
also most acute near plaques, reinforcing the idea that senile pla-222 Neuron 59, 214–225, July 31, 2008 ª2008 Elsevier Inc.ques are focal sources of toxicity. Neurites with highly elevated
[Ca2+]i are more likely to lack spines; in neurites from WT or
APP/PS1 mice with normal [Ca2+]i, the ratio of spiny to aspiny
processes is 4:1. This ratio changes almost 4-fold to nearly
1:1 among neurites with calcium overload—consistent with the
hypothesis that calcium overload is associated with spine loss
via a CaN-mediated pathway (Hsieh et al., 2006). Taken together
with recent studies, this suggests that [Ca2+]i elevations might
yield changes in the strength of synaptic connections that might,
in turn, lead to the chronic loss of spines. Thus, amyloid-b accu-
mulation impacts spines in at least two ways: the structural loss
of spiny processes near plaques as well as marked functional
impairment of calcium compartmentalization at the spinoden-
dritic interface. The magnitude of these changes in the cortex
is remarkable, with nearly 20% of all neurites exhibiting calcium
overload. These data provide in vivo support for synaptic plastic-
ity mediated changes to network properties that are crucial for
learning and memory.
We have determined at least three specific downstream func-
tional consequences of calcium overload—spinodendritic
calcium decompartmentalization, structural neuritic alterations,
and CaN activation—and highlighted an important intermediary
stage that can be targeted for therapeutic intervention—inhibit-
ing CaN activity leads to amelioration of the structural and func-
tional deficits and may have behavioral implications. A critical
factor that remains to be determined is the specific pathway
that amyloid-b activates to induce calcium influx. The effect
may be mediated by the formation of calcium-conducting pores
comprised of the Ab peptide (Arispe et al., 1993a, 1993b; Pollard
et al., 1993; Simakova and Arispe, 2006), modulation of voltage-
gated calcium channels (Brorson et al., 1995; Ekinci et al., 1999;
MacManus et al., 2000), or an Ab-mediated oxidative stress that
results in altered calcium regulation (Behl et al., 1994; Yan et al.,
1996; Yuan and Yankner, 2000).
Nonetheless, we show that mutant APP processing and sub-
sequent plaque deposition play a critical role in inducing calcium
overload in these AD models and activating calcineurin-depen-
dent neurodegenerative processes.
EXPERIMENTAL PROCEDURES
In Situ Calibration of YC3.6 in CHO Cells
CHO cells were maintained in Opti-MEM (Invitrogen, Carlsbad CA) supple-
mented with 5% FBS (Invitrogen, Carlsbad CA) and 5% CO2 at 37
C. After
adherence to 35 mm glass-bottom dishes (MatTek, Ashland MA), cells were
transiently transfected with FuGene (Roche, Indianapolis IN) dissolved in
DMEM (Invitrogen, Carlsbad CA), and 5 mg yellow cameleon-pAAV construct.
Prior to imaging, cells were washed with PBS. In situ calibration of YC3.6 was
performed by incubating dishes in mixed EGTA/CaEGTA (Invitrogen) solutions
and ionomycin (20 mM) at 37C. Hundreds of cells were sampled under multi-
photon excitation at 860 nM at ten different [Ca] conditions (0 nM to 39 mM),
and custom-written ImageJ software was used to automate cell identification
and calculate YFP-CFP ratios. A histogram of the YFP-CFP ratios always
showed a bimodal distribution with one peak (35% of the cells on average)
not sensitive to changes in [Ca]—these cells were excluded from the analysis.
The second peak shifted to higher ratios with increasing [Ca]i, and we
extracted this second peak to determine the mean YFP/CFP ratio for a given
[Ca]i. The apparent Kd and Hill coefficient (n) were determined using standard
equations (Grynkiewicz et al., 1985).
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Primary neuronal cultures were prepared as described elsewhere (Berezovska
et al., 2003). In brief, mixed cortical-hippocampal neurons were generated
from CD1 mice at embryonic day 15–16. The cells were plated on 4-well
poly-L-lysine-coated glass slides in chemically defined Neurobasal media
(Invitrogen) containing 10% fetal bovine serum for 1 hr. The neurons were
maintained in Neurobasal media containing 2% B27 supplement (Invitrogen)
for 6–12 days in vitro prior to transient transfection of yellow cameleon-
pAAV construct with FuGene. At 5–7 days in vitro, 5 mg/ml cytosine arabino-
side (Sigma) was added to the culture media to suppress the growth of
nonneuronal cells.
Yellow-Cameleon AAV Preparation
We used the construct pAAV-CBA-YC3.6-WPRE. The plasmid contained the
AAV terminal repeats (ITRs), the only remaining feature of the wild-type AAV
genome. Flanked by the ITRs, the expression cassette included the following
components in 50 to 30 order: (1) a 1.7 kb sequence containing hybrid cytomeg-
alovirus (CMV) immediate-early enhancer/chicken b-actin promoter/exon1/in-
tron; (2) yellow cameleon 3.60 cDNA; and (3) woodchuck hepatitis virus post-
transcriptional regulatory element (WPRE). The virus titer was 1.1 3 1012 viral
genomes/ml.
Animals and Surgery
Four transgenic mouse lines were used. (1) APP/PS1: mutant human PS1-DE9
and a chimeric mouse/human APPswe and age-matched nontransgenic con-
trols (Borchelt et al., 1997). Two different age groups of these mice were used
(6–8 months with plaques and 3–3.5 months without plaques). (2) Tg-2576: 695
aa isoform of APP containing the Swedish mutation and nontransgenic con-
trols. These mice were used at 17–20 months of age. (3) PS1-DE9: mutant
human PS1- DE9 alone. These mice were used at 5–6 months of age. (4)
PS1M146V. All studies were conducted with approval of the Massachusetts
General Hospital Animal Care and Use Committee and in compliance with
NIH guidelines for the use of experimental animals.
Intracortical injections and cranial window implantation have been de-
scribed previously (Skoch et al., 2005; Spires et al., 2005). For intracortical in-
jections of YC-AAV2, mice were anesthetized with isoflurane and placed in
a custom made, heated stereotaxic apparatus. The surgical site was sterilized
with betadyne and isopropyl alcohol, and a 2–3 mm incision was made in the
scalp along the midline between the ears. Burr holes were drilled in the skull,
1 mm lateral to bregma bilaterally. Using a Hamilton syringe, 4 ml of virus (titer,
4.23 1012 viral genomes/ml) was injected 1.2 mm deep in somatosensory cor-
tex (targeting layer 5 neurons) at a rate of 0.2 ml/min. After one injection in each
burr hole, the scalp was sutured, and the mouse was allowed to recover from
anesthesia on a heating pad.
After a >3 week incubation period to allow expression of YC3.6 in neurons,
mice received an intraperitoneal injection of methoxy-XO4 (10 mg/kg), a fluo-
rescent compound that crosses the blood-brain barrier and binds to amyloid
plaques (Klunk et al., 2002). The following day, a cranial window 6 mm in diam-
eter was installed under isoflurane anesthesia as described previously (Bac-
skai et al., 2002; Klunk et al., 2002). In a subset of experiments, Texas red dex-
tran (70,000 Da molecular weight; 12.5 mg/ml in sterile PBS; Invitrogen) was
injected into a lateral tail vein to provide a fluorescent angiogram.
Multiphoton Imaging
Images of YC3.6-filled neuronal processes, amyloid pathology, and blood ves-
sels were obtained using one of two microscopes: (1) a Bio-Rad 1024ES mul-
tiphoton microscope (Bio-Rad), mounted on an Olympus (Tokyo, Japan)
BX50WI upright microscope (details have been described previously, Skoch
et al., 2005) or (2) Olympus Fluoview 1000MPE with pre-chirp optics and
a fast AOM mounted on an Olympus BX61WI upright microscope. A wax
ring was placed on the edges of the coverslip of the cortical window and filled
with distilled water to create a well for an Olympus 203 dipping objective (nu-
merical aperture, 0.95). A mode-locked titanium/sapphire laser (MaiTai; Spec-
tra-Physics, Fremont, CA) generated two-photon fluorescence with 860 nm
excitation, and detectors containing three photomultiplier tubes (Hamamatsu,
Ichinocho, Japan) collected emitted light in the range of 380–480, 500–540,
and 560–650 nm (Bacskai et al., 2002). The average power reaching the braintissue ranged from 20 to 60 mW. Neurites were typically sampled 0–100 mm
below the surface of the brain, and, when possible, cell soma were sampled
350–550 mm below the surface.
Image Processing and Data Analysis
3D image stacks were processed using ImageJ and MATLAB. We exhaustively
sampled neuritic area using two techniques: (1) visual identification and neurite
tracing and (2) automated segmentation. Data were collected from 2–4 vol-
umes for each animal and statistics, nonparametric and multiple comparisons
where appropriate, were performed between groups. Ratios were converted
to [Ca2+]i using the in situ Kd and Hill coefficient with standard ratiometric
equations (RMIN = 0.58, median of lowest 5% of plaque-associated dystrophies;
RMAX = 2.48, median of top 5% of calcium overloaded processes) (Grynkiewicz
et al., 1985). Geometric mean, standard deviation, and standard error were
used to describe [Ca2+]i as they more effectively capture the central tenden-
cies of log-normal distributions. Distances to plaques were measured based
on the closest approach of a neurite to the edge of the nearest plaque. Pseu-
docolored images were created in Matlab based on the YFP/CFP ratio, which
was then converted to calcium concentration. Ratio images were created first:
R = [(YFP  Background)/(CFP  Background)]. We then applied a calibrated
color lookup table and converted the map to HSV colorspace. We used the
ratio values to supply the hue and saturation (color) and the reference image
to supply the value (intensity). For the high-resolution analysis of dendritic
spines, individual ROIs were manually traced for each spine and associated
dendrite in ImageJ. The data were imported and analyzed in MATLAB.
SUPPLEMENTAL DATA
The Supplemental Data include supplemental figures and can be found with this
article online at http://www.neuron.org/cgi/content/full/59/2/214/DC1/.
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